| Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 R Lozano, M Naghavi, K Foreman, S Lim, K Shibuya, V Aboyans, ... The lancet 380 (9859), 2095-2128, 2012 | 17968 | 2012 |
| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ... The lancet 380 (9859), 2197-2223, 2012 | 11275 | 2012 |
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati, ... The lancet 380 (9859), 2163-2196, 2012 | 10190 | 2012 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The lancet 386 (9995), 743-800, 2015 | 7037 | 2015 |
| Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 M Naghavi, AA Abajobir, C Abbafati, KM Abbas, F Abd-Allah, SF Abera, ... The lancet 390 (10100), 1151-1210, 2017 | 4833 | 2017 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … S Abdalla, F Abd-Allah, MI Abdel Aziz The Lancet, 2015 | 3324 | 2015 |
| Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying … CJL Murray, RM Barber, KJ Foreman, AA Ozgoren, F Abd-Allah, SF Abera, ... The Lancet 386 (10009), 2145-2191, 2015 | 2350* | 2015 |
| EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including … W Zhang, M Doherty, T Bardin, E Pascual, V Barskova, P Conaghan, ... Annals of the rheumatic diseases 65 (10), 1312-1324, 2006 | 2167 | 2006 |
| 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia D Khanna, JD Fitzgerald, PP Khanna, S Bae, MK Singh, T Neogi, ... Arthritis care & research 64 (10), 1431-1446, 2012 | 1940 | 2012 |
| 2016 updated EULAR evidence-based recommendations for the management of gout P Richette, M Doherty, E Pascual, V Barskova, F Becce, ... Annals of the rheumatic diseases 76 (1), 29-42, 2017 | 1702 | 2017 |
| Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 JA Salomon, T Vos, DR Hogan, M Gagnon, M Naghavi, A Mokdad, ... The Lancet 380 (9859), 2129-2143, 2012 | 1556 | 2012 |
| 2015 gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative T Neogi, TLTA Jansen, N Dalbeth, J Fransen, HR Schumacher, ... Arthritis & rheumatology 67 (10), 2557-2568, 2015 | 1410 | 2015 |
| 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis D Khanna, PP Khanna, JD Fitzgerald, MK Singh, S Bae, T Neogi, ... Arthritis care & research 64 (10), 1447-1461, 2012 | 959 | 2012 |
| Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of … H Wang, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1084-1150, 2017 | 873 | 2017 |
| European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis W Zhang, M Doherty, T Bardin, V Barskova, PA Guerne, TL Jansen, ... Annals of the rheumatic diseases 70 (4), 563-570, 2011 | 604 | 2011 |
| Effect of urate‐lowering therapy on the velocity of size reduction of tophi in chronic gout F Perez‐Ruiz, M Calabozo, JI Pijoan, AM Herrero‐Beites, A Ruibal Arthritis Care & Research 47 (4), 356-360, 2002 | 575 | 2002 |
| Serum uric acid and the risk of cardiovascular and renal disease C Borghi, EA Rosei, T Bardin, J Dawson, A Dominiczak, JT Kielstein, ... Journal of hypertension 33 (9), 1729-1741, 2015 | 552 | 2015 |
| Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the … RM Barber, N Fullman, RJD Sorensen, T Bollyky, M McKee, E Nolte, ... The lancet 390 (10091), 231-266, 2017 | 487 | 2017 |
| Gout: why is this curable disease so seldom cured? M Doherty, TL Jansen, G Nuki, E Pascual, F Perez-Ruiz, L Punzi, AK So, ... Annals of the rheumatic diseases 71 (11), 1765-1770, 2012 | 353 | 2012 |
| PEG-uricase in the management of treatment-resistant gout and hyperuricemia MR Sherman, MGP Saifer, F Perez-Ruiz Advanced drug delivery reviews 60 (1), 59-68, 2008 | 345 | 2008 |
